Literature DB >> 10438567

Annexin V staining due to loss of membrane asymmetry can be reversible and precede commitment to apoptotic death.

A K Hammill1, J W Uhr, R H Scheuermann.   

Abstract

Signal-induced apoptosis is a normal phenomenon in which cells respond to changes in their environment through a cascade of intracellular biochemical changes culminating in cell death. However, it is not clear at what point in this process the cell becomes committed to die. An early biochemical change characteristic of cells undergoing apoptosis is the loss of plasma membrane asymmetry, such that high levels of phosphatidylserine become exposed on the outside cell surface. These cells can be recognized by staining with Annexin V, which binds to phosphatidylserine with high affinity. To investigate the mechanisms controlling signal-induced apoptosis we have examined the response of a B cell lymphoma to crosslinking of the membrane immunoglobulin (mIg) receptor. We have found that many of the cells that stain positive for Annexin V are viable and can resume growth and reestablish phospholipid asymmetry once the signal is removed. These results indicate that Annexin V staining, and thus loss of membrane asymmetry, precedes commitment to apoptotic death in this system. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438567     DOI: 10.1006/excr.1999.4581

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  41 in total

1.  Strategies for tracking anastasis, a cell survival phenomenon that reverses apoptosis.

Authors:  Ho Lam Tang; Ho Man Tang; J Marie Hardwick; Ming Chiu Fung
Journal:  J Vis Exp       Date:  2015-02-16       Impact factor: 1.355

2.  Monitoring apoptosis and neuronal degeneration by real-time detection of phosphatidylserine externalization using a polarity-sensitive indicator of viability and apoptosis.

Authors:  Yujin E Kim; Jeannie Chen; Ralf Langen; Jonah R Chan
Journal:  Nat Protoc       Date:  2010-07-08       Impact factor: 13.491

3.  Generation of NO by bystander human CD8 T cells augments allogeneic responses by inhibiting cytokine deprivation-induced cell death.

Authors:  J C Choy; J S Pober
Journal:  Am J Transplant       Date:  2009-08-06       Impact factor: 8.086

4.  Lethal avian influenza A (H5N1) virus induces ataxic breathing in mice with apoptosis of pre-Botzinger complex neurons expressing neurokinin-1 receptor.

Authors:  Jianguo Zhuang; Na Zang; Chunyan Ye; Fadi Xu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-20       Impact factor: 5.464

5.  Annexin A5-functionalized nanoparticle for multimodal imaging of cell death.

Authors:  Rui Zhang; Miao Huang; Min Zhou; Xiaoxia Wen; Qian Huang; Chun Li
Journal:  Mol Imaging       Date:  2013-05       Impact factor: 4.488

6.  Engineering a polarity-sensitive biosensor for time-lapse imaging of apoptotic processes and degeneration.

Authors:  Yujin E Kim; Jeannie Chen; Jonah R Chan; Ralf Langen
Journal:  Nat Methods       Date:  2009-12-06       Impact factor: 28.547

7.  Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy.

Authors:  Eyk A Schellenberger; Alexei Bogdanov; Alexander Petrovsky; Vasilis Ntziachristos; Ralph Weissleder; Lee Josephson
Journal:  Neoplasia       Date:  2003 May-Jun       Impact factor: 5.715

8.  Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo.

Authors:  Lindsay H Levkoff; Gregory P Marshall; Heather H Ross; Maria Caldeira; Brent A Reynolds; Meryem Cakiroglu; Christopher L Mariani; Wolfgang J Streit; Eric D Laywell
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

9.  Hsf-1 and POB1 induce drug sensitivity and apoptosis by inhibiting Ralbp1.

Authors:  Sharad S Singhal; Sushma Yadav; Kenneth Drake; Jyotsana Singhal; Sanjay Awasthi
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

10.  In vivo99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation.

Authors:  Ming-fang Guo; Yaqing Zhao; Rong Tian; Lin Li; Leiming Guo; Feng Xu; Yong-mei Liu; Yong-bo He; Sen Bai; Jin Wang
Journal:  J Exp Clin Cancer Res       Date:  2009-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.